taurine has been researched along with Di Guglielmo Disease in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine was also shown to reduce significantly EC lysis mediated by lymphokine-activated killer (LAK) cells, while also significantly increasing tumor cytotoxicity." | 1.30 | Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury. ( Bouchier-Hayes, DJ; Finnegan, NM; Redmond, HP, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muirhead, KA | 1 |
| Steinfeld, RC | 1 |
| Severski, MC | 1 |
| Knauf, PA | 1 |
| Huang, CC | 1 |
| Basavappa, S | 1 |
| Ellory, JC | 1 |
| Finnegan, NM | 1 |
| Redmond, HP | 1 |
| Bouchier-Hayes, DJ | 1 |
3 other studies available for taurine and Di Guglielmo Disease
| Article | Year |
|---|---|
Anion transport heterogeneity detected by flow cytometric measurement of NBD-taurine efflux kinetics.
Topics: Anions; Cell Line; Cell Membrane; Flow Cytometry; Humans; Kinetics; Leukemia, Erythroblastic, Acute; | 1984 |
Volume-activated taurine permeability in cells of the human erythroleukemic cell line K562.
Topics: Anions; Cell Differentiation; Cell Membrane Permeability; Cell Size; Humans; Hypotonic Solutions; Le | 1996 |
Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury.
Topics: Antineoplastic Agents; Blood; Burkitt Lymphoma; Calcium; Cell Line; Cytoplasmic Granules; Cytotoxici | 1998 |